Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rheopheresis for PAD in Hemodialysis Patients
NCT03975946Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jan 2021
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial in peripheral artery disease (PAD) and critical limb ischemia (CLI) (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoints: Percentage of complete wound healing of the ischemic lesions at 8 months and Percentage of absence of major amputation at 8 months. Status: unknown.
02
Conditions
peripheral artery disease (PAD)critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT03975946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03975946.